Rad26L, also known as ERCC6L2, HEBO, BMFS2, SR278, or C9orf102, is implicated in the DNA repair processes, particularly those involved in the repair of DNA double-strand breaks through the homologous recombination repair pathway. Rad26L is believed to play a critical role in maintaining genomic stability, a key factor in preventing the accumulation of DNA damage that can lead to cancer and other age-related diseases. Mutations in Rad26L have been associated with various genetic disorders, including bone marrow failure syndromes and predisposition to certain cancers. Research into Rad26L has provided insights into its function in the complex network of DNA repair mechanisms, highlighting its importance in cellular defense against DNA damage and its potential as a target for therapeutic interventions in diseases caused by genomic instability. The study of Rad26L and its interactions with other components of the DNA repair machinery continues to be a significant area of interest for understanding the molecular basis of genomic maintenance and its implications for human health.
Informations pour la commande
Nom du produit | Ref. Catalogue | COND. | Prix HT | QTÉ | Favoris | |
Anticorps Rad26L (B-11) | sc-376609 | 200 µg/ml | $316.00 | |||
Rad26L (B-11) peptide neutralisant | sc-376609 P | 100 µg/0.5 ml | $68.00 |